Those data are consistent with our finding that high IGFBP2 expression in CRC tumors is significantly associated with death and recurrence in two independent datasets of CRC patients (Table 3,Table 4;Figure 3). This evidence concerns the gene IGFBP2 and colorectal carcinoma.